TY  - GEN
AU  - Hadoux,Julien
AU  - Favier,Judith
AU  - Scoazec,Jean-Yves
AU  - Leboulleux,Sophie
AU  - Al Ghuzlan,Abir
AU  - Caramella,Caroline
AU  - Déandreis,Désirée
AU  - Borget,Isabelle
AU  - Loriot,Céline
AU  - Chougnet,Cécile
AU  - Letouzé,Eric
AU  - Young,Jacques
AU  - Amar,Laurence
AU  - Bertherat,Jérome
AU  - Libé,Rosella
AU  - Dumont,Frédéric
AU  - Deschamps,Frédéric
AU  - Schlumberger,Martin
AU  - Gimenez-Roqueplo,Anne Paule
AU  - Baudin,Eric
TI  - SDHB mutations are associated with response to temozolomide in patients with metastatic pheochromocytoma or paraganglioma
SN  - 1097-0215
PY  - 2014///1125
KW  - Adrenal Gland Neoplasms
KW  - drug therapy
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Agents, Alkylating
KW  - therapeutic use
KW  - Biomarkers, Tumor
KW  - genetics
KW  - Brain Neoplasms
KW  - DNA Methylation
KW  - DNA Modification Methylases
KW  - DNA Repair Enzymes
KW  - Dacarbazine
KW  - analogs & derivatives
KW  - Female
KW  - Follow-Up Studies
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Mutation
KW  - Neoplasm Metastasis
KW  - Neoplasm Staging
KW  - Paraganglioma
KW  - Pheochromocytoma
KW  - Polymerase Chain Reaction
KW  - Prognosis
KW  - Promoter Regions, Genetic
KW  - Retrospective Studies
KW  - Succinate Dehydrogenase
KW  - Survival Rate
KW  - Temozolomide
KW  - Tumor Suppressor Proteins
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1002/ijc.28913
ER  -